Nedocromil
Also sold as: Alocril
Related Medications
These drugs share a pharmacologic classification but are NOT interchangeable. Listing here does not imply clinical equivalence. A physician must evaluate each drug individually for the patient's specific condition.
Classification: Decreased Histamine Release (source: RxClass/NLM)
- olopatadineMast Cell StabilizerSame Class
- cromolynMast Cell StabilizerSame Class
- zafirlukastRespiratory AgentSame Class
- ivacaftorRespiratory AgentSame Class
- benztropineRespiratory AgentSame Class
- benzonatateRespiratory AgentSame Class
- palivizumabRespiratory AgentSame Class
- acetylcysteineRespiratory AgentSame Class
- calfactantRespiratory AgentSame Class
- poractant alfaRespiratory AgentSame Class
- nirsevimabRespiratory AgentSame Class
- deutivacaftorRespiratory AgentSame Class
- clesrovimabRespiratory AgentSame Class
- doxapramRespiratory AgentSame Class
- doxylamineRespiratory AgentSame Class
Insurance Coverage User-Reported
No community coverage data yet for nedocromil.
Coverage data submission coming soon.
Drug Information
Indications & Uses
INDICATIONS AND USAGE ALOCRIL ® ophthalmic solution is indicated for the treatment of itching associated with allergic conjunctivitis.
Dosage & Administration
DOSAGE AND ADMINISTRATION The recommended dosage is one or two drops in each eye twice a day. ALOCRIL ® ophthalmic solution should be used at regular intervals. Treatment should be continued throughout the period of exposure (i.e., until the pollen season is over or until exposure to the offending allergen is terminated), even when symptoms are absent.
Side Effects (Adverse Reactions)
ADVERSE REACTIONS The most frequently reported adverse experience was headache (~40%). Ocular burning, irritation and stinging, unpleasant taste, and nasal congestion have been reported to occur in 10 – 30% of patients. Other events occurring between 1 – 10% included asthma, conjunctivitis, eye redness, photophobia, and rhinitis. Some of these events were similar to the underlying ocular disease being studied.
Contraindications
CONTRAINDICATIONS ALOCRIL ® ophthalmic solution is contraindicated in those patients who have shown hypersensitivity to nedocromil sodium or to any of the other ingredients.
Verify with Primary Sources
Always verify clinical information with authoritative sources.
Medical Disclaimer: Information on this page is sourced from FDA-approved labeling data and is for educational reference only. It does not constitute medical advice. This information does not establish a provider-patient relationship. Always verify with current prescribing information and consult a licensed healthcare professional before any clinical decision. Read full disclaimer.
Data sourced from RxNorm (NLM/NIH), FDA Orange Book, OpenFDA, DailyMed. Last updated: 2026-03-02.